Showing results (441-450 of 567) with videos related to

Sort By:
Pageof 57
Clinical Genitourinary Cancer|January 29, 2019
Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder CancerDi Maria Jiang, Haiyan Jiang, Peter W M Chung, et al.
ACS Applied Materials & Interfaces|January 15, 2014
Enhanced field emission properties from CNT arrays synthesized on Inconel superalloyS Sridhar, L Ge, C S Tiwary, et al.
Plos One|April 15, 2016
Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast CancerAruna Korlimarla, Jyothi S Prabhu, Jose Remacle, et al.
Clinical Genitourinary Cancer|March 26, 2022
Comprehensive genomic profiling of treatment resistant metastatic castrate sensitive prostate cancer reveals high frequency of potential therapeutic targetsCoralea Kappel, Di Maria Jiang, Bryan Wong, et al.
Future Oncology (London, England)|July 29, 2025
SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinomaThomas B Powles, Enrique Grande, Nimira Alimohamed, et al.
Journal of Orthopaedic Trauma|August 21, 2025
Outcomes Following Distal Femur Replacement for Fracture: A Multi-Institutional Retrospective ReviewDavid C Landy, Jeffrey A Foster, Wyatt G S Southall, et al.
The Journal of Urology|March 14, 2018
The Bladder Utility Symptom Scale: A Novel Patient Reported Outcome Instrument for Bladder CancerNathan Perlis, Murray D Krahn, Kirstin E Boehme, et al.
The Oncologist|April 7, 2019
Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC)Aaron R Hansen, Ian F Tannock, Arnoud Templeton, et al.
Diabetes|November 28, 2023
Interactive Effects of Empagliflozin and Hyperglycemia on Urinary Amino Acids in Individuals With Type 1 DiabetesLuxcia Kugathasan, Vikas S Sridhar, Leif Erik Lovblom, et al.
BJUI Compass|April 23, 2026
Addition of immune checkpoint inhibitors to intravesical BCG for high-risk BCG-naïve non-muscle invasive bladder cancer: Systematic review and meta-analysisRenil S Titus, Carlos Riveros, Eusebio Luna Velasquez, et al.
Pageof 57